84 related articles for article (PubMed ID: 27879546)
1. Early Lymphocyte Recovery and Outcome in Osteosarcoma.
Lee L; Fei L; Pope J; Wagner LM
J Pediatr Hematol Oncol; 2017 Apr; 39(3):179-183. PubMed ID: 27879546
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of early lymphocyte recovery in pediatric osteosarcoma.
Moore C; Eslin D; Levy A; Roberson J; Giusti V; Sutphin R
Pediatr Blood Cancer; 2010 Dec; 55(6):1096-102. PubMed ID: 20734401
[TBL] [Abstract][Full Text] [Related]
3. Absolute lymphocyte count recovery after allogeneic hematopoietic stem cell transplantation predicts clinical outcome.
Kim HT; Armand P; Frederick D; Andler E; Cutler C; Koreth J; Alyea EP; Antin JH; Soiffer RJ; Ritz J; Ho VT
Biol Blood Marrow Transplant; 2015 May; 21(5):873-80. PubMed ID: 25623931
[TBL] [Abstract][Full Text] [Related]
4. Absolute lymphocyte count at day 28 independently predicts event-free and overall survival in adults with newly diagnosed acute lymphoblastic leukemia.
Sun D; Elson P; Liedtke M; Medeiros BC; Earl M; Alizadeh A; Bates J; Sekeres MA; Coutre S; Kalaycio M; Sobecks R; Copelan E; Advani AS
Am J Hematol; 2012 Oct; 87(10):957-60. PubMed ID: 22729847
[TBL] [Abstract][Full Text] [Related]
5. Higher infused lymphocyte dose predicts higher lymphocyte recovery, which in turn, predicts superior overall survival following autologous hematopoietic stem cell transplantation for multiple myeloma.
Hiwase DK; Hiwase S; Bailey M; Bollard G; Schwarer AP
Biol Blood Marrow Transplant; 2008 Jan; 14(1):116-24. PubMed ID: 18158968
[TBL] [Abstract][Full Text] [Related]
6. Early lymphocyte recovery as a prognostic indicator for high-risk Ewing sarcoma.
De Angulo G; Hernandez M; Morales-Arias J; Herzog CE; Anderson P; Wolff J; Kleinerman ES
J Pediatr Hematol Oncol; 2007 Jan; 29(1):48-52. PubMed ID: 17230066
[TBL] [Abstract][Full Text] [Related]
7. Early lymphocyte reconstitution is associated with improved transplant outcome after cord blood transplantation.
Tedeschi SK; Jagasia M; Engelhardt BG; Domm J; Kassim AA; Chinratanalab W; Greenhut SL; Goodman S; Greer JP; Schuening F; Frangoul H; Savani BN
Cytotherapy; 2011 Jan; 13(1):78-82. PubMed ID: 20586668
[TBL] [Abstract][Full Text] [Related]
8. Pirarubicin versus doxorubicin in neoadjuvant/adjuvant chemotherapy for stage IIB limb high-grade osteosarcoma: does the analog matter?
Yu W; Tang L; Lin F; Yao Y; Shen Z
Med Oncol; 2015 Jan; 32(1):307. PubMed ID: 25432694
[TBL] [Abstract][Full Text] [Related]
9. Clinical impact of early recovery of peripheral blood absolute lymphocyte count after frontline autologous stem cell transplantation for diffuse large B-cell lymphoma.
Kim Y; Kim SJ; Cheong JW; Cho H; Chung H; Lee JY; Jang JE; Min YH; Kim JS
Hematol Oncol; 2017 Dec; 35(4):465-471. PubMed ID: 27440113
[TBL] [Abstract][Full Text] [Related]
10. Prognostic meaning of neutrophil to lymphocyte ratio (NLR) and lymphocyte to monocyte ration (LMR) in newly diagnosed Hodgkin lymphoma patients treated upfront with a PET-2 based strategy.
Romano A; Parrinello NL; Vetro C; Chiarenza A; Cerchione C; Ippolito M; Palumbo GA; Di Raimondo F
Ann Hematol; 2018 Jun; 97(6):1009-1018. PubMed ID: 29442162
[TBL] [Abstract][Full Text] [Related]
11. Absolute lymphocyte count recovery after induction chemotherapy predicts superior survival in acute myelogenous leukemia.
Behl D; Porrata LF; Markovic SN; Letendre L; Pruthi RK; Hook CC; Tefferi A; Elliot MA; Kaufmann SH; Mesa RA; Litzow MR
Leukemia; 2006 Jan; 20(1):29-34. PubMed ID: 16281063
[TBL] [Abstract][Full Text] [Related]
12. Experience of pediatric osteosarcoma of the extremity at a single institution in Taiwan: prognostic factors and impact on survival.
Hung GY; Yen HJ; Yen CC; Chen WM; Chen PC; Wu HT; Chiou HJ; Chang WH; Hsu HE
Ann Surg Oncol; 2015 Apr; 22(4):1080-7. PubMed ID: 25323470
[TBL] [Abstract][Full Text] [Related]
13. Minimum absolute lymphocyte count during radiotherapy as a new prognostic factor for nasopharyngeal cancer.
Cho O; Oh YT; Chun M; Noh OK; Hoe JS; Kim H
Head Neck; 2016 Apr; 38 Suppl 1():E1061-7. PubMed ID: 26040623
[TBL] [Abstract][Full Text] [Related]
14. Early lymphocyte recovery predicts longer survival after autologous peripheral blood stem cell transplantation in multiple myeloma.
Kim H; Sohn HJ; Kim S; Lee JS; Kim WK; Suh C
Bone Marrow Transplant; 2006 Jun; 37(11):1037-42. PubMed ID: 16708062
[TBL] [Abstract][Full Text] [Related]
15. Lymphocyte recovery as a positive predictor of prolonged survival after autologous peripheral blood stem cell transplantation in T-cell non-Hodgkin's lymphoma.
Kim H; Sohn HJ; Kim SE; Kang HJ; Park S; Kim S; Kim WK; Lee JS; Suh C
Bone Marrow Transplant; 2004 Jul; 34(1):43-9. PubMed ID: 15107814
[TBL] [Abstract][Full Text] [Related]
16. Clinical impact of absolute lymphocyte count on day 30 after unmanipulated haploidentical blood and marrow transplantation for pediatric patients with hematological malignancies.
Chang YJ; Zhao XY; Huo MR; Xu LP; Liu DH; Liu KY; Huang XJ
Am J Hematol; 2011 Feb; 86(2):227-30. PubMed ID: 21264916
[TBL] [Abstract][Full Text] [Related]
17. Early lymphocyte recovery at 28 d post-transplant is predictive of reduced risk of relapse in patients with acute myeloid leukemia transplanted with peripheral blood stem cell grafts.
Michelis FV; Messner HA; Loach D; Uhm J; Gupta V; Lipton JH; Seftel MD; Kuruvilla J; Kim DD
Eur J Haematol; 2014 Oct; 93(4):273-80. PubMed ID: 24725056
[TBL] [Abstract][Full Text] [Related]
18. Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.
Meyers PA; Schwartz CL; Krailo MD; Healey JH; Bernstein ML; Betcher D; Ferguson WS; Gebhardt MC; Goorin AM; Harris M; Kleinerman E; Link MP; Nadel H; Nieder M; Siegal GP; Weiner MA; Wells RJ; Womer RB; Grier HE;
J Clin Oncol; 2008 Feb; 26(4):633-8. PubMed ID: 18235123
[TBL] [Abstract][Full Text] [Related]
19. Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.
Caronia D; Patiño-García A; Milne RL; Zalacain-Díez M; Pita G; Alonso MR; Moreno LT; Sierrasesumaga-Ariznabarreta L; Benítez J; González-Neira A
Pharmacogenomics J; 2009 Oct; 9(5):347-53. PubMed ID: 19434073
[TBL] [Abstract][Full Text] [Related]
20. Absolute Lymphocyte Count (ALC) after Induction Treatment Predicts Survival of Pediatric Patients with Acute Lymphoblastic Leukemia.
Farkas T; Müller J; Erdelyi DJ; Csoka M; Kovacs GT
Pathol Oncol Res; 2017 Oct; 23(4):889-897. PubMed ID: 28138921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
